Steris (STE) said Tuesday that a jury trial since December against its Isomedix Operations unit ended in a mistrial on Friday and the court will schedule the case for re-trial.
The mistrial was declared at plaintiff's request during jury deliberations after a juror was dismissed, reducing the jury to fewer than 12 people, the company said.
The case involves allegations by an individual plaintiff that ethylene oxide emissions from a sterilization plant owned and operated by Isomedix from 2005 to 2008 in Waukegan, Illinois, caused personal injury, Steris said.
Shares of Steris were up more than 3% in early trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.